Study explores the role of N6-methyladensoine methylation and COVID-19

A recent study summarized the recent advances in the role of N6-methyladenosine (m6A) methylation in COVID-19.

A bespoke genetic therapy is helping Susannah. Can similar drugs be made at scale for other rare diseases?

Will it work? It was the question everyone around Susannah Rosen kept asking. Since infancy, she’d lived with a rare neurologic disease. She’d struggled to

August 9, 2024

New FDA guidance gives manufacturers limits for nitrosamines

After assessing comments from industry players, the FDA has finally issued its final guidance with recommendations on acceptable intake limits for nitrosamine impurities in drugs.

August 5, 2023

Largest study using machine learning in neuroimaging sets new benchmark for major depression diagnosis

A benchmark classification of major depressive disorder (MDD) using machine learning (ML).

January 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.